IREN Announces Pricing of Ordinary Shares Offering to Fund the Repurchase of Convertible Notes
IREN (NASDAQ: IREN) priced a registered direct offering of 39,699,102 ordinary shares at $41.12 per share, expected to close on December 8, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
IREN (NASDAQ: IREN) priced a registered direct offering of 39,699,102 ordinary shares at $41.12 per share, expected to close on December 8, 2025. Proceeds from the offering approximate $1,632.4 million and are intended to fund a negotiated repurchase of existing convertible notes and related capped calls, with repurchases announced of approximately $227.7 million principal of 2030 notes and $316.6 million principal of 2029 notes for an aggregate repurchase price of approximately $1,632.4 million. IREN also priced private offerings of $1 billion 0.25% notes due 2032 and $1 billion 1.00% notes due 2033 (plus optional upsizes). Offerings and repurchases are subject to customary closing conditions and may close concurrently on December 8, 2025.
Positive
- Registered direct offering of $1,632.4M proceeds
- Repurchase reduces outstanding convertible debt principal by ~$544.3M
- Concurrent private pricing of $2.0B convertible notes (2032/2033)
Negative
- Offering issues 39.7M ordinary shares causing potential dilution
- Aggregate repurchase price (~$1,632.4M) materially uses cash or financing
- Repurchases and concurrent offerings subject to customary closing conditions
Details
News Market Reaction – IREN
On Dec 3, the day this news came out, IREN closed 6.91% above the previous close.
Data tracked by StockTitan Argus for the Dec 3 session.
Key Figures
- Ordinary shares offered
- 39,699,102 shares
- Registered direct offering
- Offering price
- $41.12 per share
- Registered direct equity offering
- 2030 notes conversion price
- $16.81 per share
- Existing 2030 convertible senior notes
- 2029 notes conversion price
- $13.64 per share
- Existing 2029 convertible senior notes
- 2030 notes repurchased
- $227.7 million principal
- Existing 2030 Convertible Notes
- 2029 notes repurchased
- $316.6 million principal
- Existing 2029 Convertible Notes
- Aggregate repurchase price
- $1,632.4 million
- Repurchase of Existing Convertible Notes
- Capped call cost
- $174.8 million
- Capped call transactions tied to new Convertible Notes
Historical Context
-
Closed $2.3B convertible notes and $1,632.4M equity placement to refinance debt.
-
Priced 39.7M-share direct offering to fund repurchase of existing convertibles.
-
Priced $2.0B 2032/2033 convertible notes plus concurrent equity placement.
-
Announced proposed $1.0B 2032 and $1.0B 2033 convertible offerings.
-
Proposed ordinary share offering to fund repurchase of 2029 and 2030 notes.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
registered direct offering financial
convertible senior notes financial
capped call transactions financial
prospectus supplement regulatory
base prospectus regulatory
convertible notes financial
aggregate principal amount financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced the pricing of a registered direct offering of 39,699,102 ordinary shares at a price of
Concurrently with the pricing of the Offering, IREN entered into one or more separate, privately negotiated transactions with a limited number of holders of IREN’s outstanding
IREN also announced today the pricing of its previously announced private offering of
The proceeds from the Offering will be approximately
The completion of the Offering is not contingent on the completion of the Concurrent Offering or the Repurchase, and the completion of the Concurrent Offering is not contingent on the completion of the Offering or the Repurchase.
Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are acting as placement agents for the Offering.
IREN is conducting the Offering pursuant to an effective shelf registration statement, including a base prospectus, under the Securities Act of 1933, as amended. The Offering is being made only by means of a separate prospectus supplement and the accompanying prospectus. Copies of the preliminary prospectus supplement and accompanying prospectus relating to the Offering may be obtained by contacting Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by telephone at 1-800-831-9146; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at 1-866-471-2526, by facsimile at 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com; or J.P. Morgan Securities LLC, Attention: c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by emailing prospectus-eq_fi@jpmchase.com or postsalemanualrequests@broadridge.com. Before you invest in the Offering, you should read the applicable prospectus supplement relating to the Offering and accompanying prospectus, the registration statement and the other documents that IREN has filed with the Securities and Exchange Commission as incorporated by reference therein, for more complete information about IREN and the Offering. Investors may obtain these documents for free by visiting the SEC’s website at www.sec.gov.
This press release shall not constitute an offer to sell, or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. This press release also shall not constitute an offer to purchase or a solicitation of an offer to sell the Existing Convertible Notes.
About IREN
IREN is a leading AI Cloud Service Provider, delivering large-scale GPU clusters for AI training and inference. IREN’s vertically integrated platform is underpinned by its expansive portfolio of grid-connected land and data centers in renewable-rich regions across the U.S. and Canada.
Contacts
Investors
ir@iren.com
Media
media@iren.com
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the completion of the Offering, the Concurrent Offering and the Repurchase and the expected amount and intended use of the net proceeds. Forward-looking statements represent IREN’s current expectations, beliefs, and projections regarding future events and are subject to known and unknown uncertainties, risks, assumptions and contingencies, many of which are outside IREN’s control and that could cause actual results to differ materially from those described in or implied by the forward-looking statements. Among those risks and uncertainties are market conditions, the satisfaction of the closing conditions related to the Offering and risks relating to IREN’s business, including those described in periodic reports that IREN files from time to time with the SEC. IREN may not consummate the Offering described in this press release and, if the Offering is consummated, cannot provide any assurances regarding its ability to effectively apply the net proceeds after funding the cost of entering into the capped call transactions as described above. The forward-looking statements included in this press release speak only as of the date of this press release, and IREN does not undertake any obligation to update the forward-looking statements included in this press release for subsequent developments, except as may be required by law. For a further discussion of factors that could cause IREN’s future results to differ materially from any forward-looking statements, see the section entitled “Risk Factors” in IREN’s Annual Report on Form 10-K for the year ended June 30, 2025 and other risks described in documents filed by IREN from time to time with the Securities and Exchange Commission.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.